RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,404 | -57.4% | 56,298 | 0.0% | 0.00% | – |
| Q2 2023 | $61,928 | -7.6% | 56,298 | 0.0% | 0.00% | – |
| Q1 2023 | $66,995 | +327.2% | 56,298 | +434.8% | 0.00% | – |
| Q4 2022 | $15,684 | -7.7% | 10,526 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | +112.5% | 10,526 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | -57.9% | 10,526 | 0.0% | 0.00% | – |
| Q1 2022 | $19,000 | +5.6% | 10,526 | 0.0% | 0.00% | – |
| Q4 2021 | $18,000 | -18.2% | 10,526 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | -8.3% | 10,526 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | -86.0% | 10,526 | -82.8% | 0.00% | – |
| Q1 2021 | $171,000 | -6.6% | 61,199 | -4.7% | 0.00% | – |
| Q4 2020 | $183,000 | +31.7% | 64,201 | -3.1% | 0.00% | – |
| Q3 2020 | $139,000 | -57.0% | 66,231 | -6.7% | 0.00% | – |
| Q2 2020 | $323,000 | -45.1% | 70,981 | -1.3% | 0.00% | – |
| Q1 2020 | $588,000 | -53.4% | 71,908 | +4.4% | 0.00% | – |
| Q4 2019 | $1,262,000 | +90.6% | 68,878 | +15.3% | 0.00% | – |
| Q3 2019 | $662,000 | +11.6% | 59,753 | +2.5% | 0.00% | – |
| Q2 2019 | $593,000 | +76.5% | 58,297 | +1.7% | 0.00% | – |
| Q1 2019 | $336,000 | -18.0% | 57,328 | -0.6% | 0.00% | – |
| Q4 2018 | $410,000 | +18.8% | 57,679 | +18.8% | 0.00% | – |
| Q3 2018 | $345,000 | +45.0% | 48,561 | +2.6% | 0.00% | – |
| Q2 2018 | $238,000 | -59.7% | 47,346 | -11.8% | 0.00% | – |
| Q1 2018 | $591,000 | +23.1% | 53,665 | +3.5% | 0.00% | – |
| Q4 2017 | $480,000 | +2.1% | 51,864 | -1.0% | 0.00% | – |
| Q3 2017 | $470,000 | +32.4% | 52,391 | +3.7% | 0.00% | – |
| Q2 2017 | $355,000 | +127.6% | 50,532 | +182.7% | 0.00% | – |
| Q1 2017 | $156,000 | – | 17,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |